Use of tryptophan-synthesizing bacteria to enhance intestinal motility

利用色氨酸合成菌增强肠道蠕动

• 批准号: 10453687
• 负责人: Brigitte Lavoie
• 金额: $ 19.12万
• 依托单位: UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-07-19 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10453687
• 关键词: Agonist; Applications Grants; Aromatic-L-Amino-Acid Decarboxylases; Bacillus subtilis; Bacteria; Behavior; Biochemical; Blood specimen; Brain; Cell Degranulation; Cells; Chemicals; Clostridium difficile; Constipation; Diarrhea; Diet; Digestion; Digestive System Disorders; Disease; Drug Targeting; Elements; Endocrine Glands; Enteral; Enterobacteriaceae; Enterochromaffin Cells; Epithelial; Epithelial Cells; Essential Amino Acids; Formulation; Future; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Motility; Gastrointestinal tract structure; Genes; Goals; Goblet Cells; Health; Human; Hydroxyindoleacetic Acid; Indoles; Infection; Inflammatory; Inflammatory Bowel Diseases; Intestinal Motility; Intestinal Secretions; Intestines; Investigation; Knowledge; Kynurenine; Large Intestine; Link; Location; Measures; Mediating; Motor; Mucous Membrane; Mus; Nausea and Vomiting; Neurons; Outcome Measure; Patients; Pattern; Pharmacology; Physiological Processes; Population; Probiotics; Production; Property; Proteins; Recurrence; Reflex action; Reporter; Research Design; Role; Serotonin; Serotonin Receptors 5-HT4; Signal Transduction; Signaling Molecule; Small Intestines; Societies; Source; Symptoms; Testing; Tissues; Transgenic Organisms; Tryptamines; Tryptophan; Tryptophan 5-monooxygenase; Tryptophan Synthase; Waste Products; Water; base; cell motility; design; dietary; effective therapy; fecal transplantation; gut bacteria; gut microbiome; gut microbiota; improved; innovation; intestinal epithelium; microbiome; microbiota; microorganism; neurochemistry; novel; novel strategies; optogenetics; probiotic therapy; receptor; response; serotonin receptor; spatiotemporal; success; symptom treatment; targeted treatment; translational approach; treatment strategy; virtual

Project Summary/Abstract Functional and inflammatory disorders of the gastrointestinal tract represent a significant burden to patients and to society. These disorders are difficult to treat, and recurrence of symptoms is common. As a result, there are ongoing efforts to develop more effective treatment options. The gut microbiome is now recognized as a dynamic entity that can influence a wide variety of physiological processes, ranging from the integrity of the intestinal epithelial barrier to brain neurochemistry and behavior. The clear success of fecal microbiome transplants in the treatment of C. difficile infections has highlighted the potential of utilizing the microbiome as a means of improving health. The studies that are included in this grant application are designed to exploit specific biochemical properties of certain bacterial strains to test novel treatment strategies for functional bowel disorders. We will test the hypothesis that tryptophan-synthesizing bacteria increase active tryptophan metabolites that enhance colonic motility through the activation of 5-HT4 receptors. Tryptophan is an essential amino acid that is typically acquired from the diet, but can also be produced by enteric bacteria. In addition to being incorporated into proteins, it serves as a precursor molecule for serotonin (5-HT), or it can be enzymatically converted to form kynurenine and its derivatives. In the epithelium of the intestine, enterochromaffin cells convert tryptophan to 5-HT. When 5-HT is released from these cells it triggers enteric reflexes that increase propulsive motility and epithelial secretion. Changes in 5-HT signaling have been identified in functional and inflammatory conditions of the gut, and drugs targeting 5-HT receptors have been developed for the treatment of constipation and diarrhea. In Specific Aim 1 of this proposal, we will test the hypothesis that treatment of mice with a bacterial strain that is known to produce tryptophan, and which has been used safely in probiotic formulations, results in increased mucosal 5- HT levels and enhanced intestinal motility. Specific Aim 2 of this proposal is aimed at determining the mechanisms by which tryptophan producing bacteria promote motility. The 5-HT receptor that is most directly linked to propulsive motility is the 5-HT4 receptor. We will test whether this receptor is involved and determine what tissues express the receptor that mediate this effect. We will also examine what changes in motility patterns and neuronal activity are associated with enhanced propulsive motility, and we will test whether increasing the tryptophan metabolite, tryptamine, can enhance the motility augmenting effect of tryptophan-producing bacteria. The results of these studies could provide a predictive translational strategy for the use of probiotic bacteria, with known biochemical features, for the treatment of constipation.

项目摘要/摘要 胃肠道的功能性和炎症性疾病给患者带来了沉重的负担。 以及对社会的影响。这些疾病很难治疗，而且症状复发很常见。结果, 目前正在努力开发更有效的治疗方案。肠道微生物群现在被识别出来 作为一个动态实体，它可以影响各种各样的生理过程，从 肠上皮屏障对脑神经化学和行为的影响。粪便微生物组的明显成功 移植治疗艰难梭菌感染突出了利用微生物群作为一种 改善健康的手段。包括在这项拨款申请中的研究旨在利用 某些细菌菌株的特定生化特性用于测试功能性肠道治疗的新策略 精神错乱。我们将验证色氨酸合成菌增加活性色氨酸的假设 通过激活5-HT4受体增强结肠动力的代谢物。 色氨酸是一种必需的氨基酸，通常从饮食中获得，但也可以通过 肠道细菌。除了被结合到蛋白质中，它还是5-羟色胺的前体分子 (5-羟色胺)，或者它可以被酶转化为犬尿氨酸及其衍生物。 在肠上皮中，肠嗜铬细胞将色氨酸转化为5-羟色胺。当5-羟色胺 从这些细胞释放出来，它会触发肠道反射，从而增加推进运动和上皮分泌。 5-羟色胺信号的变化已经在肠道的功能和炎症条件下被发现，药物 靶向5-羟色胺受体已被开发用于治疗便秘和腹泻。以特定的目标 在这项提议中，我们将检验这样一个假设，即用一种已知的细菌菌株治疗小鼠 产生色氨酸，并已在益生菌配方中安全使用，导致粘膜5- 羟色胺水平和增强的肠动力。 本提案的具体目标2旨在确定色氨酸的产生机制。 细菌促进运动。与推进运动最直接相关的5-羟色胺受体是5-羟色胺4 受体。我们将测试该受体是否参与，并确定哪些组织表达该受体 调停这一效应。我们还将研究运动模式和神经元活动的变化 与增强的推进运动有关，我们将测试增加色氨酸代谢物， 色胺，可以增强色氨酸产生菌的动力增强作用。 这些研究的结果可以为益生菌的使用提供一个预测性的翻译策略。 具有已知生物化学特性的细菌，用于治疗便秘。

项目成果

Interplay of Broccoli/Broccoli Sprout Bioactives with Gut Microbiota in Reducing Inflammation in Inflammatory Bowel Diseases.

• DOI: 10.1016/j.jnutbio.2022.109238
• 发表时间: 2022-11
• 期刊: The Journal of nutritional biochemistry
• 作者: Johanna M. Holman;Molly Hurd;P. Moses;G. Mawe;Zhang Tao;S. Ishaq;Yanyan Li

Monitoring Gut Epithelium Serotonin and Melatonin Overflow Provides Spatial Mapping of Inflammation.

• DOI: 10.1002/cbic.202200334
• 发表时间: 2023-01-17
• 期刊: Chembiochem : a European journal of chemical biology

Direct and indirect mechanisms by which the gut microbiota influence host serotonin systems.

• DOI: 10.1111/nmo.14346
• 发表时间: 2022-10
• 期刊: NEUROGASTROENTEROLOGY AND MOTILITY
• 影响因子: 3.5
• 作者: Legan, Theresa B.;Lavoie, Brigitte;Mawe, Gary M.
• 通讯作者: Mawe, Gary M.

Tryptophan-synthesizing bacteria enhance colonic motility.

色氨酸合成细菌增强结肠蠕动。

• DOI: 10.1111/nmo.14629
• 发表时间: 2023
• 期刊: Neurogastroenterology and motility
• 影响因子: 3.5
• 作者: Legan,TheresaB;Lavoie,Brigitte;Norberg,Emilia;Ley,IsabellaC;Tack,Stephanie;Tompkins,ThomasA;Wargo,MatthewJ;Mawe,GaryM
• 通讯作者: Mawe,GaryM